Emerging markets like India will gain capital allocation: Dr Reddy’s GV Prasad

Emerging markets like India will gain capital allocation: Dr Reddy’s GV Prasad Dr Reddy#39;s Laboratories sprung a surprise on Wednesday when it announced that it will acquire the domestic business of Wockhardt Pharma for Rs 1,850 crore

No comments:

Post a Comment